IOP-Lowering Efficacy of Brinzolamide 1.0% Added to Travoprost 0.004%/Timolol 0.5% Fixed Combination as Adjunctive Therapy

Phase 4

Completed

• Conditions: Glaucoma

• Registration Number: NCT00382226
• Lead Sponsor: Alcon Research

Brief Summary

Uncontrolled glaucoma patients being treated with a prostaglandin agent alone or in combination with adjunctive drugs in fixed or unfixed combinations, will be switched from their current therapy to travoprost/timolol fixed combination and either Azopt or placebo

Detailed Description

Not available

Study Timeline

• Study Start: 2006-09
• Study First Submitted: 2006-09-27
• Study First Submitted QC: 2006-09-27
• Study First Posted: 2006-09-28
• Primary Completion: 2007-08
• Study Completion: 2007-08
• Status Verified: 2008-04
• Last Update Submitted: 2016-11-17
• Last Update Posted: 2016-11-18

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 195

Inclusion Criteria

• Glaucoma

Exclusion Criteria

• Under 18

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
IOP lowering

Secondary Outcome Measures

Name	Time	Method
safety

Trial Locations

Locations (1)

Sydney Study Site; 🇦🇺 Sydney, New South Wales, Australia